Analysts’ updated eps estimates for Friday, August 25th:

American River Bankshares (NASDAQ:AMRB) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “American River Bankshares is the parent company of American River Bank, a regional bank in Northern California with 10 full service branches in Sacramento, Sonoma, Placer and Amador Counties as well as two loan production offices in the San Francisco Bay Area. The Bank specializes in giving business owners more REACH by offering financial expertise and exceptional service to complement a full suite of banking products and lending solutions such as secured and unsecured lines of credit, commercial real estate loans, equipment financing, payroll and merchant card services. For more information, call (800) 544-0545 or visit AmericanRiverBank.com. “

Ardmore Shipping Corporation (NYSE:ASC) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Bodycote Plc (NASDAQ:BYPLF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bodycote PLC provides thermal processing services through heat treatment, metal joining, surface technology and Hot Isostatic Pressing. It serves aerospace, defense, automotive, power generation, oil & gas, construction, medical and transportation industry. Bodycote PLC is headquartered in Macclesfield, the United Kingdom. “

China Mobile (Hong Kong) (NYSE:CHL) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “China Mobile offers mobile communications services principally using Global System for Mobile Communications, or GSM, which is a pan-European mobile telephone system based on digital transmission and mobile communications network architecture with roaming capabilities. Our GSM networks reach all cities and counties and most major roads and highways in our service regions. “

China Unicom (Hong Kong) (NYSE:CHU) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “China Unicom Limited is engaged in the provision of cellular, paging, long distance, data and internet services in the People’s Repulic of China. “

Cellectar Biosciences (NASDAQ:CLRB) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. “

Corvus Pharmaceuticals (NASDAQ:CRVS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Corvus Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of immuno-oncology therapies to harness the immune system to attack cancer cells. Its products include CPI-444, Adenosine production inhibitor, Adenosine A2B antagonist and Interleukin-2 (IL-2)-inducible T cell kinase (ITK) inhibitors. Corvus Pharmaceuticals, Inc. is based in Burlingame, California. “

Community Trust Bancorp (NASDAQ:CTBI) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Community Trust Financial Services Corporation was incorporated under the laws for the purpose of becoming a bank holding company for Community Trust Bank. The Company is intended to facilitate the Bank’s ability to serve its customers’ requirements for financial services. The primary activity of the Company currently is, and is expected to remain for the foreseeable future, the ownership and operation of the Bank. “

Evotec AG (NASDAQ:EVTCY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $42.00 price target on the stock. According to Zacks, “EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries “

First Connecticut Bancorp (NASDAQ:FBNK) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “First Connecticut Bancorp Inc. is a banking company. Farmington Bank provides commercial, consumer and banking services to businesses, individuals and governments across Central Connecticut. It also offers residential mortgage loan services along with brokerage and investment advisory services. The Company’s consumer loans include installment, demand, revolving credit and collateral loans. Its installment and collateral consumer loans generally consist of loans on new and used automobiles, loans collateralized by deposit accounts and unsecured personal loans. “

Flushing Financial Corporation (NASDAQ:FFIC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “FLUSHING FINANCIAL CORP. is a unitary savings and loan holding company, which, under existing laws, is generally not restricted as to types of business activities in which it may engage, provided that the subsidiary, continues to be a qualified thrift lender. Under the regulations of the Office of Thrift Supervision, the subsidiary is a qualified thrift lender if its ratio of qualified thrift investments to portfolio assets is 65% or more, on a monthly average basis in nine of every 12 months. “

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.